Yanhong Li

Yanhong Li

Auto-generated profile, based on publicly available information

Yanhong Li

Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
ZCZhaolei Cui
Zhaolei Cui
YLYanhong Li
Yanhong Li
YLYingying Lin
Yingying Lin
CZChaoqiang Zheng
Chaoqiang Zheng
LLLingqing Luo
Lingqing Luo
YSYang Sun
Yang Sun
Objective: The established link between posttranslational modifications of histone and non-histone lysine (K) residues in cell metabolism, and their role in cancer progression, is well-documented. However, the lactylation expression signature in triple-negative breast cancer (TNBC) remains underexplored.Methods: We conducted a comprehensive lactylproteome profiling of eight pairs of TNBC samples and their matched adjacent tissues. This was achieved through 4-Dimensional label-free quantitative proteomics combined with lactylation analysis (4D-LFQP-LA). The expression of identified lactylated proteins in TNBC was detected using immunoblotting and immunohistochemistry (IHC) with specific primary antibodies, and their clinicopathological and prognostic significance was evaluated.Results: Our analysis identified 58 lactylation sites on 48 proteins, delineating the protein lactylation alteration signature in TNBC. Bioinformatic and functional analyses indicated that these lactylated proteins play crucial roles in regulating key biological processes in TNBC. Notably, lactylation of lysine at position 12 (H4K12lac) in the histone H4 domain was found to be upregulated in TNBC. Further investigations showed a high prevalence of H4K12lac upregulation in TNBC, with positive rates of 93.19% (137/147) and 92.93% (92/99) in TNBC tissue chip and validation cohorts, respectively. H4K12lac expression correlated positively with Ki-67 and inversely with overall survival (OS) in TNBC (HR [hazard ratio] =2.813, 95%CI [credibility interval]: 1.242-6.371, P=0.0164), suggesting its potential as an independent prognostic marker (HR=3.477, 95%CI: 1.324-9.130, P=0.011).Conclusions: Lactylation is a significant post-translational modification in TNBC proteins. H4K12lac emerges as a promising biomarker for TNBC, offering insights into the lactylation profiles of TNBC proteins and linking histone modifications to clinical implications in TNBC.

3 June 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
WSWei Shi
Wei Shi
Zheng ChenZheng Chen
Zheng Chen
LSLiping Shi
Liping Shi
SJSiyuan Jiang
Siyuan Jiang
JZJianguo Zhou
Jianguo Zhou
JTJoseph Ting
Joseph Ting
Early-onset sepsis (EOS) poses a substantial risk to very preterm infants, necessitating the prevalent administration of empirical antibiotics in the neonatal intensive care unit (NICU). Puopolo et al1 reported that more than one-third of the extremely preterm infants in their study were categorized as low risk for EOS, with an incidence of 0.5%. In these low-risk groups, prolonged empirical antibiotic treatment (≥5 days) was observed in approximately 35% of cases.1 Recent studies1-3 have suggested a potential association of prolonged antibiotic therapy with both increased mortality and a higher incidence of adverse neonatal outcomes, including bronchopulmonary dysplasia (BPD), within this vulnerable population. However, these studies often relegated BPD as a secondary outcome, lacking comprehensive consideration of relevant confounding factors. Moreover, the literature has reported inconsistent results in this domain.4-6 The reported association may be influenced by factors such as culture-proven sepsis bacteremia, illness severity, and early respiratory disease.

7 February 2026 in Neoplasia
Verified
Journal Article
Open access
MGMengli Gao
Mengli Gao
YRYuge Ran
Yuge Ran
JQJuan Qi
Juan Qi
XHXiao Han
Xiao Han
YWYali Wei
Yali Wei
HSHongyun Shi
Hongyun Shi
Mast cells (MCs) are immunometabolic sentinels, yet their heterogeneity and functional specialization in breast cancer (BRCA) remain unclear. We hypothesized that arginine metabolism defines transcriptionally and functionally distinct MC subpopulations that shape the BRCA microenvironment. We integrated single-cell RNA-seq (GSE161529; 272,592 cells, 38 clusters), spatial transcriptomics (GSE243022) and bulk RNA-seq (TCGA, GSE42568). After harmony batch-correction and Seurat-Louvian clustering, MCs were split by median arginine score (AUCell/UCell/AddModuleScore/singscore) into high- (HAS) and low-activity (LAS) subsets. Monocle2 pseudotime, CellChat, hdWGCNA (power = 15), LASSO-Cox and MiloR were used to trace differentiation, communication, prognostic value and triple-negative breast cancer (TNBC) enrichment. Functional validation of the model-prioritized gene OAT was subsequently conducted in clinical tissues and breast cancer cell lines through loss-of-function assays. HAS cells represented 18.7 % of all MCs and were enriched in TNBC (OR = 2.4, p < 0.001). They displayed higher differentiation potential (CytoTRACE: 0.72 vs 0.41, p < 0.001) and trajectory progression (pseudotime τ = 0.68). Arginine score correlated with differentiation (r = 0.52) and tumor risk signature (TRS, r = 0.35). CellChat revealed 1.8-fold increased incoming signals in HAS; VEGF and TGF-β pathways were most active (p < 0.001). hdWGCNA identified 19 modules; cyan and green modules (kME > 0.9) contained 214 HAS-up genes driving cell-cycle and arginine/glutamine metabolism. A five-gene (ARG1, NOS2, ASL, OAT, AZIN1) LASSO model predicted 5-year survival (AUC = 0.82; HR = 1.68, p < 0.001). Spatial maps confirmed ASL+ MC hotspots in tumor cores (AUC = 0.89 vs normal). Experimentally, OAT expression was elevated in TNBC tissues and cell lines. Knockdown of OAT impaired proliferation, induced apoptosis, suppressed migration/invasion, and modulated apoptosis- and EMT-related protein expression, functionally supporting its role in BRCA progression. Arginine metabolism stratifies MCs into pro-tumorigenic HAS and quiescent LAS subsets; ASL-high MCs constitute a metabolically wired, highly communicating population that fuels TNBC progression and furnishes an exploitable prognostic signature. OAT, a key HAS-associated gene, promotes breast cancer aggressiveness through proliferation, survival, and invasion.

22 March 2025 in The American Journal of Pathology
Verified
Journal Article
Closed access
FTFei Teng
Fei Teng
RZRenjie Zhang
Renjie Zhang
YWYunyi Wang
Yunyi Wang
QLQian Li
Qian Li
BWBei Wang
Bei Wang
YLYanhong Li
Yanhong Li

30 June 2016 in BMB Reports
Verified
Journal Article
Open access
PDF file
SSSuqin Shen
Suqin Shen
JZJie Zuo
Jie Zuo
HFHuan Feng
Huan Feng
MBMeirong Bai
Meirong Bai
CWChenji Wang
Chenji Wang
LYLong Yu
Long Yu
TCP10L synergizes with MAD1 in transcriptional suppression and cell cycle arrest through mutual interaction Hepatocellular carcinoma;MAX dimerization protein 1;Protein degradation;Protein-protein interaction;T-complex protein 10A homolog 2; T-complex protein 10A homolog 2 (TCP10L) was previously demonstrated to be a potential tumor suppressor in human hepatocellular carcinoma (HCC). However, little is known about the molecular mechanism. MAX dimerization protein 1 (MAD1) is a key transcription suppressor that is involved in regulating cell cycle progression and Myc-mediated cell transformation. In this study, we identified MAD1 as a novel TCP10L-interacting protein. The interaction depends on the leucine zipper domain of both TCP10L and MAD1. TCP10L, but not the interaction-deficient TCP10L mutant, synergizes with MAD1 in transcriptional repression, cell cycle G1 arrest and cell growth suppression. Mechanistic exploration further revealed that TCP10L is able to stabilize intracellular MAD1 protein level. Consistently, the MAD1-interaction-deficient TCP10L mutant exerts no effect on stabilizing the MAD1 protein. Taken together, our results strongly indicate that TCP10L stabilizes MAD1 protein level through direct interaction, and they cooperatively regulate cell cycle progression.

4 March 2019 in Journal of Asian Natural Products Research
Verified
Journal Article
Closed access
YLYan-Hong Li
Yan-Hong Li
HLHong-Rui Li
Hong-Rui Li
CYChun-Tao Yang
Chun-Tao Yang
KTKai Tian
Kai Tian
CYCui Yang
Cui Yang
XHXiangzhong Huang
Xiangzhong Huang
Three new diterpenoids, dumetoranes A (1) and B (2), melanocane B (3), together with four known ones including melanocane A (4), ent-15S,16-dihydroxypimar-8(14)-en-19-oic acid (5), ent-pimara-8(14),15-diene-19-oic acid (6), and ent-pimara-8(14),15-diene-19-ol (7) were obtained from the ethanol extract of the roots of Aralia dumetorum. Their structure elucidation was achieved by the methods of spectroscopic HRMS, IR, NMR, and by comparison with literature. The cytotoxicities of compounds 1–3 and 5 were assayed by in vitro MTT methods.